XML 28 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Statements of Cash Flows (Unaudited) (USD $)
9 Months Ended 12 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Dec. 31, 2012
Dec. 31, 2011
Cash flows from operating activities        
Net loss $ (599,592) $ (1,147,998) $ (1,659,586) $ (1,956,639)
Adjustments to reconcile net loss to net cash used in operating activities        
Depreciation 183,250 110,018 169,644 97,115
Loss (gain) on disposal of property and equipment 0 (368) (368) 1,613
Stock-based compensation expense 175,787 154,747 216,094 235,840
Amortization of deferred financing costs 42,322 60,142 78,539 74,403
Lease incentives received from landlord, net of amortization of deferred rent related to lease incentives 88,258 766,082 861,802 0
Change in operating assets and liabilities        
(Increase) Decrease in Accounts receivable, trade (426,705) (250,800) (53,010) (208,244)
Inventories 247,202 (343,255) (150,441) (95,470)
Prepaid expenses and other current assets 34,654 (32,470) (84,287) (28,067)
Increase (Decrease) in        
Accounts payable (21,994) 661,180 459,389 286,035
Accrued compensation and other current liabilities (94,439) 129,786 227,718 (59,756)
Accrued interest, related parties 556,664 547,875 733,430 670,986
Deferred rent (8,780) 46,189 76,010 12,267
Deferred revenue (109,167) (15,000) (20,000) (20,000)
Net cash provided by (used in) operating activities 67,460 686,128 854,934 (989,917)
Cash flows from investing activities        
Cash received from sale of property and equipment 0 1,400 1,400 2,100
Purchase of property and equipment (235,109) (1,171,863) (1,151,720) (93,530)
Net cash used in investing activities (235,109) (1,170,463) (1,150,320) (91,430)
Proceeds from exercise of common stock options and warrants 50,458 0 0 0
Proceeds from notes payable 0 475,000 475,000 1,095,000
Net cash provided by financing activity 50,458 475,000 475,000 1,095,000
Net increase (decrease) in cash and cash equivalents (117,191) (9,335) 179,614 13,653
Cash and cash equivalents - beginning of period 196,478 16,864 16,864 3,211
Cash and cash equivalents - end of period 79,287 7,529 196,478 16,864
Non-cash financing activities        
Deferred financing costs from issuance of warrants (See Note 7) $ 0 $ 137,955 $ 137,955 $ 89,225